Abstract:Humans have for a long time contemplated the link between diet and disease. As early as 400 BC, Hippocrates, commonly referred to as the father of western medicine, stated, “let food be thy medicine and let medicine be thy food”. Today, a poor diet is still considered one of the major risk factors for common complex diseases such as cardiovascular disease (CVD). CVD refers to a class of diseases that involves heart and blood vessels. According to WHO, CVD is one of the leading causes of morbidity and mortality in the industrialized world [8]. The cause of CVD is multifactorial, of which dyslipidemia plays a central role. Dyslipidemia is a state of elevated low density lipoprotein cholesterol (LDL-C), triglycerides, and/or reduced high density lipoprotein cholesterol (HDL-C). In the past, the treatment strategy of dyslipidemia has involved pharmacological intervention (e.g. statins or fibrates) to lower serum LDL-C and triglycerides. However, it is not until recently that the importance of diet and lifestyle are emphasized in clinical treatment and prevention of dyslipidemia. The classic ‘diet-heart’ hypothesis postulates that high intake of foods rich in fat raise the level of circulating cholesterol and triglycerides in the blood, thereby contributing to the risk of heart disease. However, recent research efforts have shown this hypothesis to be overly simplistic, where total fat intake as percentage of total energy intake is not as important as initially believed, whereas fat quality seems to be much more important. Studies have shown that replacement of saturated fat with mono- or poly- unsaturated fat appears to be beneficial for health whereas there seems to be no clear beneficial effect if saturated fat is replaced with (refined) carbohydrates. Like many other complex diseases, dyslipidemia and CVD are products of a genetic predisposition and environmental risk factors. Large-scale population genetics studies have identified 164 common genetic variants (single nucleotide polymorphisms [SNPs]) associated with lipid levels. It is plausible that environmental factors, including diet, physical activity, alcohol consumption and smoking, may interact with genetic variants to modify circulating lipid levels in the context of dyslipidemia. Studying gene-environment interactions may help explore novel mechanisms of disease, and inform future personalized nutrition/medicine based on genetic make-up. A new research field combining genetics, nutrition and biochemistry emerged in 2000, known as nutrigenetics, to study inter-individual variation in response to diet. If dyslipidemia can be effectively intervened upon through lifestyle, a large proportion of CVD cases could be delayed or even avoided. Furthermore, targeted diet and lifestyle interventions can protect against drug overconsumption, abuse or adverse side effects. Last but not least, compared to the massive costs related to disease diagnosis and treatment, the use of lifestyle interventions to control and prevent disease may prove to be a much more economical and effective way to improve public health interventions targeting populations susceptible to CVD and related traits. The Nunavik Inuit Health Survey comprises a small cohort of adult Inuits (N=553), in which interactions between 35 SNPs (in 20 genes) and components of dietary fat intake on plasma lipid levels were investigated]. 14 interactions with total fat intake, and 13 interactions with saturated fat intake were observed on blood lipid traits (total cholesterol, LDL-C, HDL-C and triglycerides), with an additive effect observed when looking at the combined genetic burden. It is meaningful to replicate the same analysis within a population of European ancestry to verify the reliability of the findings by Rudkowska et al., thus furthering our understanding on the biological mechanism of dyslipidemia.

A Gene-Diet Interaction-Based Score Predicts Response to Dietary Fat in the Women’s Health Initiative

Can Dietary Fat Intake Modify Genetic Associations with Blood Lipid Level? Observations from a Swedish Cohort Study

Genetic and Environmental Factors in Cardiometabolic Risk

Genetic Predictors of Change in Waist Circumference and Waist-to-Hip Ratio With Lifestyle Intervention: The Trans-NIH Consortium for Genetics of Weight Loss Response to Lifestyle Intervention

Gene–Diet Interaction on Body Weight Maintenance

1469-P: Gene-Level Gene–Mediterranean Diet Interaction Detection Influencing Inflammatory and Glycemic Biomarkers in 137,000 UK Biobank Participants

Improving adherence to healthy dietary patterns, genetic risk, and long term weight gain: gene-diet interaction analysis in two prospective cohort studies

Abstract 18754: Genetic Predisposition to Coronary Artery Disease and Changes in Lipid Profile in Response to 2-Year Weight-loss Diet Intervention: the Pounds Lost Trial

Investigating Gene-Diet Interactions Impacting the Association Between Macronutrient Intake and Glycemic Traits

Evidence of gene-nutrient interaction association with waist circumference, cross-sectional analysis

Alignment of diet prescription to genotype does not promote greater weight loss success in women with obesity participating in an exercise and weight loss program

Abstract 14433: Dietary Protein Intake Modifies the Genetic Risk on Insulin Resistance in the Pounds Lost Trial

Gene-Dietary Fat Interactions on Obesity among Postmenopausal Women Participated in the Women's Health Initiative Study

Decomposed interaction testing improves detection of genetic modifiers of the relationship of dietary omega-3 fatty acid intake and its plasma biomarkers with hsCRP in the UK Biobank

Using Machine Learning to Predict Obesity Based on Genome-Wide and Epigenome-Wide Gene–Gene and Gene–Diet Interactions

Epigenomic Assessment of Cardiovascular Disease Risk and Interactions with Traditional Risk Metrics

Metabolomics-Based Biomarker for Dietary Fat and Associations with Chronic Disease Risk in Postmenopausal Women1

Genome-Wide Interaction Analysis With DASH Diet Score Identified Novel Loci for Systolic Blood Pressure

A Mendelian Randomization Approach Using 3-HMG-Coenzyme-A Reductase Gene Variation to Evaluate the Association of Statin-Induced Low-Density Lipoprotein Cholesterol Lowering With Noncardiovascular Disease Phenotypes

Pharmacogenomics of CRP response to statins: a GIST consortium study

Abstract P535: Associations of Genetically Determined Favourable and Unfavourable Adiposity Across the Phenome